Kimberly A Yonkers
Biographic Data
| ID | 6753177 |
|---|---|
| NAME | Kimberly A Yonkers |
| GIVEN NAMES | Kimberly A |
| FAMILY NAME | Yonkers |
| SIGNATURE | YONKERS K A |
| AFFILIATIONS | Yale University |
| ORCID | 0000-0001-7326-7636 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 6 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1995 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 1 |
Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy
Findings support the need to screen women for depression early in pregnancy and to integrate assessments of pregnancy context into the evaluation of potential risk factors
Early Childhood Adversity and Pregnancy Outcomes
Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy
Perinatal Depression and Birth Outcomes in a Healthy Start Project
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder
BACKGROUND: Better characterization of safety and efficacy of multiple doses of selective serotonin reuptake inhibitors for the treatment of a wider range of symptoms of premenstrual dysphoric disorder (PMDD) will provide clinicians with flexibility to provide symptom relief along with acceptable tolerability. This study was designed to assess the efficacy and tolerability of multiple doses of paroxetine controlled release (CR) in PMDD. METHODS: …
Premenstrual exacerbation of depression
Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy
Findings support the need to screen women for depression early in pregnancy and to integrate assessments of pregnancy context into the evaluation of potential risk factors
Premenstrual exacerbation of depression
Paroxetine Controlled Release for Premenstrual Dysphoric Disorder
BACKGROUND: Better characterization of safety and efficacy of multiple doses of selective serotonin reuptake inhibitors for the treatment of a wider range of symptoms of premenstrual dysphoric disorder (PMDD) will provide clinicians with flexibility to provide symptom relief along with acceptable tolerability. This study was designed to assess the efficacy and tolerability of multiple doses of paroxetine controlled release (CR) in PMDD. METHODS: …
Perinatal Depression and Birth Outcomes in a Healthy Start Project
Clinical Correlates of Prescription Opioid Analgesic Use in Pregnancy
Early Childhood Adversity and Pregnancy Outcomes
Association of Pregnancy Contexts with Depression and Low Social Support in Early Pregnancy
Findings support the need to screen women for depression early in pregnancy and to integrate assessments of pregnancy context into the evaluation of potential risk factors
Medicine (6 works) · Internal Medicine (5 works) · Psychiatry (5 works) · Maternal Mental Health During Pregnancy and Postpartum (4 works) · Pregnancy (4 works) · Anxiety (3 works) · Depression (economics (3 works) · Psychology (3 works) · Birth weight (2 works) · Gestational age (2 works)